Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study

IntroductionKidney transplant recipients (KTR) are at high risk of developing severe COVID-19. However, vaccine response in this population is severely impaired with humoral response rates of 36–54 and 55–69% after two or three doses of SARS-COV-2 vaccines, respectively. Triple immunosuppression and...

Full description

Bibliographic Details
Main Authors: Florina Regele, Andreas Heinzel, Karin Hu, Lukas Raab, Farsad Eskandary, Ingrid Faé, Sieglinde Zelzer, Georg A. Böhmig, Gregor Bond, Gottfried Fischer, Rainer Oberbauer, Roman Reindl-Schwaighofer
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Medicine
Subjects:
SARS-CoV-2
kidney transplantation
immunosuppressant
mycophenolate
azathioprine
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.914424/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.914424/full

Similar Items